000 01566 a2200421 4500
005 20250513190054.0
264 0 _c20000114
008 200001s 0 0 ger d
022 _a1018-8843
024 7 _a10.1159/000022290
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFehr, M K
245 0 0 _a[Chemotherapy of endometrial cancer revisited].
_h[electronic resource]
260 _bGynakologisch-geburtshilfliche Rundschau
_c1999
300 _a110-20 p.
_bdigital
500 _aPublication Type: Comparative Study; English Abstract; Journal Article; Review
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdenocarcinoma, Clear Cell
_xdrug therapy
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCombined Modality Therapy
650 0 4 _aCystadenocarcinoma, Papillary
_xdrug therapy
650 0 4 _aEndometrial Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHormones
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLymphatic Metastasis
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aPrognosis
650 0 4 _aRadiotherapy, Adjuvant
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTime Factors
700 1 _aWight, E
700 1 _aHaller, U
773 0 _tGynakologisch-geburtshilfliche Rundschau
_gvol. 39
_gno. 3
_gp. 110-20
856 4 0 _uhttps://doi.org/10.1159/000022290
_zAvailable from publisher's website
999 _c10378046
_d10378046